Boston Scientific: Adding Another Growth Engine With Penumbra (NYSE:BSX)

Group 1 - Boston Scientific (BSX) is actively pursuing its M&A strategy while also achieving impressive organic growth, with nearly 20% organic sales growth reported [1] - The company's shares are currently commanding premium earnings valuations, indicating strong market confidence [1] - The investment group "Value In Corporate Events" focuses on identifying opportunities in major corporate events such as IPOs, mergers & acquisitions, and earnings reports, providing coverage of 10 major events monthly [1]